PMID- 21306686
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20121002
LR  - 20110210
IS  - 1009-3419 (Print)
IS  - 1009-3419 (Linking)
VI  - 6
IP  - 5
DP  - 2003 Oct 20
TI  - [A clinical study on paclitaxel plus cisplatin combined therapy in the treatment 
      of non-small cell lung cancer].
PG  - 386-7
LID - 10.3779/j.issn.1009-3419.2003.05.16 [doi]
AB  - BACKGROUND: To evaluate the results of combined chemotherapy with paclitaxel 
      (PTX, taxol) plus cisplatin (DDP) in the treatment of advanced non small cell 
      lung cancer (NSCLC). METHODS: From January 1997 to December 2002, forty-seven 
      patients with advanced non-small cell lung cancer received PTX 135-180 mg/m(2) by 
      intravenous infusion, on day 1, and DDP 40 mg/time by intravenous infusion,on 
      days 1-3. The treatment was repeated every 3 weeks, up to 2 or 3 cycles. RESULTS: 
      Forty-six patients were evaluable for efficacy. One patient got complete response 
      (2.2%), and 16 got partial response (34.8%), with an overall response rate of 
      37.0%. The main toxicities were myelosuppression, nausea and vomiting, and other 
      side effects were mild. CONCLUSIONS: A high response rate can be obtained in 
      advanced NSCLC by PTX plus DDP. PTX is a promising antitumor agent with tolerable 
      toxicity.
FAU - Chen, Zhen
AU  - Chen Z
AD  - Department of Chemotherapy, Shandong Provincial Tumor Hospital, Jinan, Shandong 
      250117, P.R.China.
FAU - Wang, Zhehai
AU  - Wang Z
FAU - Li, Changzheng
AU  - Li C
LA  - chi
PT  - English Abstract
PT  - Journal Article
PL  - China
TA  - Zhongguo Fei Ai Za Zhi
JT  - Zhongguo fei ai za zhi = Chinese journal of lung cancer
JID - 101126433
EDAT- 2003/10/20 00:00
MHDA- 2003/10/20 00:01
CRDT- 2011/02/11 06:00
PHST- 2011/02/11 06:00 [entrez]
PHST- 2003/10/20 00:00 [pubmed]
PHST- 2003/10/20 00:01 [medline]
AID - 10.3779/j.issn.1009-3419.2003.05.16 [doi]
PST - ppublish
SO  - Zhongguo Fei Ai Za Zhi. 2003 Oct 20;6(5):386-7. doi: 
      10.3779/j.issn.1009-3419.2003.05.16.